Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,099,476
  • Shares Outstanding, K 104,292
  • Annual Sales, $ 4,416 M
  • Annual Income, $ 192,790 K
  • 60-Month Beta 1.83
  • Price/Sales 2.09
  • Price/Cash Flow 17.62
  • Price/Book 2.84
Trade SYNH with:

Options Overview

Details
  • Implied Volatility 44.58%
  • Historical Volatility 16.30%
  • IV Percentile 47%
  • IV Rank 52.65%
  • IV High 58.86% on 01/27/21
  • IV Low 28.70% on 05/26/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 1,279
  • Open Int (30-Day) 1,579

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.82
  • Number of Estimates 4
  • High Estimate 0.84
  • Low Estimate 0.80
  • Prior Year 0.46
  • Growth Rate Est. (year over year) +78.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.05 +1.06%
on 07/19/21
92.25 -5.73%
on 07/09/21
-2.00 (-2.25%)
since 06/25/21
3-Month
78.75 +10.43%
on 05/04/21
92.25 -5.73%
on 07/09/21
-0.35 (-0.40%)
since 04/27/21
52-Week
50.26 +73.00%
on 09/24/20
92.25 -5.73%
on 07/09/21
+25.47 (+41.42%)
since 07/27/20

Most Recent Stories

More News
Syneos Health Names Michael Brooks Chief Development Officer

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael Brooks to the newly created role of Chief Development Officer....

SYNH : 87.19 (-0.07%)
Syneos Health Schedules Second Quarter 2021 Earnings Call for Monday, August 9, 2021

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to its earnings...

SYNH : 87.19 (-0.07%)
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical...

SYNH : 87.19 (-0.07%)
Dr. David S. Wilkes Appointed to Syneos Health Board of Directors

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of David S. Wilkes, M.D., to the Company's Board of Directors.

SYNH : 87.19 (-0.07%)
Syneos' (SYNH) New Patient Consortium to Drive Innovation

Syneos' (SYNH) Patient Voice Consortium incorporates patient perspective across wide range of communities to guide product development lifecycle.

AMED : 252.05 (-1.22%)
CPSI : 31.00 (-1.27%)
PETQ : 35.91 (-0.58%)
SYNH : 87.19 (-0.07%)
Syneos Health Launches Patient Voice Consortium

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today launched its Patient Voice Consortium. The Consortium is a cross-functional hub designed to share...

SYNH : 87.19 (-0.07%)
Syneos Health Announces Pricing of Secondary Offering of Common Stock

Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization, today announced the pricing of the previously announced underwritten...

SYNH : 87.19 (-0.07%)
Syneos Health Announces Secondary Offering of Common Stock

Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization, today announced it commenced an underwritten secondary offering...

SYNH : 87.19 (-0.07%)
Syneos Health to Present at Upcoming Investor Conferences

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to present at two upcoming investor conferences:

SYNH : 87.19 (-0.07%)
Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior Director, Clinical Operations and Clinical Development Services,...

SYNH : 87.19 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

3rd Resistance Point 91.56
2nd Resistance Point 90.47
1st Resistance Point 88.86
Last Price 87.19
1st Support Level 86.16
2nd Support Level 85.07
3rd Support Level 83.46

See More

52-Week High 92.25
Last Price 87.19
Fibonacci 61.8% 76.21
Fibonacci 50% 71.26
Fibonacci 38.2% 66.30
52-Week Low 50.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar